This drug offers 99.9% protection against HIV, but there’s a catch

Jun 22, 2025 | 15:53 IST

Image: AI

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete protection. However, its cost — ₹24 lakh per shot — may make it inaccessible in India

A new drug promising 99.9% protection against HIV received approval from the US Food and Drug Administration (FDA) a few days ago, but Mumbai’s HIV rights activists are sceptical about its practical impact in India.

TOI

TOI

This drug offers 99.9% protection against HIV, but there’s a catch

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete protection. However, its cost — ₹24 lakh per shot — may make it inaccessible in India

{{{h1}}}

{{{h1}}}

{{{h3}}}

{{{offerprice}}}

{{{h3}}}

{{{offerprice}}}

{{{h1}}}

{{{h1}}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

Your Privacy is Important to us

Opt out of the sale or sharing of personal information

TOI

This drug offers 99.9% protection against HIV, but there’s a catch

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete protection. However, its cost — ₹24 lakh per shot — may make it inaccessible in India

{{{h1}}}

{{{h1}}}

{{{h3}}}

{{{offerprice}}}

{{{h3}}}

{{{offerprice}}}

{{{h1}}}

{{{h1}}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}

{{{h1}}}

{{h2}}